|
A Contemporary Comparison of the Effect of Shunt Type in Hypoplastic Left Heart Syndrome on the Hemodynamics and Outcome at Fontan Completion
|
Jean A. Ballweg1, Troy E. Dominguez1, Chitra Ravishankar1, Peter J. Gruber1, Gil Wernovsky1, J. W. Gaynor1, Susan C. Nicolson1, Thomas L. Spray1, Sarah Tabbutt2; 1Children's Hospital of Philadelphia, Philadelphia, PA; 2University of California San Francisco, San Francisco, CA
Objective: We previously reported no difference in morbidity or mortality in infants undergoing stage 1 and stage 2 reconstruction with either a modified BT shunt (mBTS) or a right ventricular to pulmonary artery conduit (RV-PA). We now compare the hemodynamics and peri-operative course at the time of the Fontan completion and report longer-term survival. Methods: We retrospectively reviewed the echocardiograms, catheterizations and hospital records of all patients who previously underwent stage 1 reconstruction (S1R) between January 2002 and May 2005 and subsequent surgical procedures, as well as cross-sectional analysis of hospital survivors. Results: 176 pts with HLHS and variants underwent initial S1R with either mBTS (n = 114) or RV-PA conduit (n = 62). The median duration of follow-up was 53 months (range 1 - 76). By Kaplan-Meier analysis, shunt type did not influence survival or freedom from transplant at 5 years (RV-PA 61%, 95% CL: 47-72% vs. mBTS 70%, 95% CL: 60-77%, p = 0.55). Nintey three pts underwent Fontan (62 mBTS and 31 RV-PA) with 98% (91/93) early survival. Pre-Fontan there was a trend towards higher pulmonary artery pressure (13 ± 8 mmHg vs. 11 ± 3 mmHg, p = 0.05) and common atrial pressure (8 ± 2 mmHg vs. 7 ± 2 mmHg, p = 0.06) in pts with RV-PA conduits. By echo evaluation, there was a trend towards more qualitative moderate to severe ventricular dysfunction (RV-PA 31% (11/35) vs. mBTS 17% (11/65), p= 0.08) and moderate to severe atrioventricular valve regurgitation (RV-PA 38% (13/34) vs. mBTS 17% (11/65), p=0.07) in the RV-PA group. Use of diuretic therapy, ACE inhibition, reflux medications and tube feedings were no different between groups. There was a trend towards increased digoxin use in the RV-PA group (RV-PA 71% (25/35) vs. 65% mBTS (45/69), p = 0.06). Overall 5 pts underwent heart transplantation (RV-PA 4 vs. mBTS 1, p= 0.1) prior to Fontan. There was no difference in age or weight at Fontan, bypass time, ICU or hospital length of stay, post-operative pleural effusions or need for reoperation between groups. Conclusion: Interim analyses continue to suggest that there is no advantage of one shunt type over another. Longer term follow-up of a randomized patient population remains of utmost importance.
Back to 2009 Annual Meeting
Back to Program Outline
Back to Main Program
|
|